191 related articles for article (PubMed ID: 29592883)
21. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.
Staquicini FI; Ozawa MG; Moya CA; Driessen WH; Barbu EM; Nishimori H; Soghomonyan S; Flores LG; Liang X; Paolillo V; Alauddin MM; Basilion JP; Furnari FB; Bogler O; Lang FF; Aldape KD; Fuller GN; Höök M; Gelovani JG; Sidman RL; Cavenee WK; Pasqualini R; Arap W
J Clin Invest; 2011 Jan; 121(1):161-73. PubMed ID: 21183793
[TBL] [Abstract][Full Text] [Related]
22. Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).
Heffeter P; Popovic-Bijelic A; Saiko P; Dornetshuber R; Jungwirth U; Voevodskaya N; Biglino D; Jakupec MA; Elbling L; Micksche M; Szekeres T; Keppler BK; Gräslund A; Berger W
Curr Cancer Drug Targets; 2009 Aug; 9(5):595-607. PubMed ID: 19508176
[TBL] [Abstract][Full Text] [Related]
23. Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase.
Narasimhan J; Antholine WE; Chitambar CR
Biochem Pharmacol; 1992 Dec; 44(12):2403-8. PubMed ID: 1335254
[TBL] [Abstract][Full Text] [Related]
24. Gallium and other main group metal compounds as antitumor agents.
Jakupec MA; Keppler BK
Met Ions Biol Syst; 2004; 42():425-62. PubMed ID: 15206110
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens.
Hijazi S; Visaggio D; Pirolo M; Frangipani E; Bernstein L; Visca P
Front Cell Infect Microbiol; 2018; 8():316. PubMed ID: 30250828
[TBL] [Abstract][Full Text] [Related]
26. Gallium and its competing roles with iron in biological systems.
Chitambar CR
Biochim Biophys Acta; 2016 Aug; 1863(8):2044-53. PubMed ID: 27150508
[TBL] [Abstract][Full Text] [Related]
27. SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1.
Jeong SM; Lee J; Finley LW; Schmidt PJ; Fleming MD; Haigis MC
Oncogene; 2015 Apr; 34(16):2115-24. PubMed ID: 24909164
[TBL] [Abstract][Full Text] [Related]
28. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
Knorr GM; Chitambar CR
Anticancer Res; 1998; 18(3A):1733-7. PubMed ID: 9673397
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effect of gallium maltolate on fecal Salmonella shedding in cattle.
Nerren JR; Edrington TS; Bernstein LR; Farrow RL; Genovese KG; Callaway TR; Anderson RC; Krueger NA; Duke SE; Nisbet DJ
J Food Prot; 2011 Apr; 74(4):524-30. PubMed ID: 21477464
[TBL] [Abstract][Full Text] [Related]
31. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
32. Gallium in cancer treatment.
Jakupec MA; Keppler BK
Curr Top Med Chem; 2004; 4(15):1575-83. PubMed ID: 15579097
[TBL] [Abstract][Full Text] [Related]
33. Gallium-containing anticancer compounds.
Chitambar CR
Future Med Chem; 2012 Jun; 4(10):1257-72. PubMed ID: 22800370
[TBL] [Abstract][Full Text] [Related]
34. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
DeLeon K; Balldin F; Watters C; Hamood A; Griswold J; Sreedharan S; Rumbaugh KP
Antimicrob Agents Chemother; 2009 Apr; 53(4):1331-7. PubMed ID: 19188381
[TBL] [Abstract][Full Text] [Related]
35. Gallium maltolate, a promising low toxicity drug with curative effect on mice chronically infected with Trypanosoma evansi.
Rosa LD; Oliveira CB; Chaúque BJM; Grando TH; Gressler LT; Bottari N; Monteiro SG
Acta Trop; 2024 Apr; 252():107148. PubMed ID: 38354996
[TBL] [Abstract][Full Text] [Related]
36. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
37. Haploinsufficiency of Transferrin Receptor 1 Impairs Angiogenesis with Reduced Mitochondrial Complex I in Mice with Limb Ischemia.
Okuno K; Naito Y; Yasumura S; Sawada H; Asakura M; Masuyama T; Ishihara M
Sci Rep; 2019 Sep; 9(1):13658. PubMed ID: 31541184
[TBL] [Abstract][Full Text] [Related]
38. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway.
Huang S; Zhang D; Yi X; Liu C; Jian C; Yu A
Med Oncol; 2023 Nov; 40(12):353. PubMed ID: 37952032
[TBL] [Abstract][Full Text] [Related]
39. Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
Xiao C; Fu X; Wang Y; Liu H; Jiang Y; Zhao Z; You F
PLoS One; 2020; 15(12):e0243812. PubMed ID: 33351833
[TBL] [Abstract][Full Text] [Related]
40. Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates.
Davies NP; Suryo Rahmanto Y; Chitambar CR; Richardson DR
J Pharmacol Exp Ther; 2006 Apr; 317(1):153-62. PubMed ID: 16373528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
